Skip to main content
Top
Published in: Globalization and Health 1/2020

Open Access 01-12-2020 | Antibiotic | Research

Promoting rational antibiotic use in Turkey and among Turkish migrants in Europe – implications of a qualitative study in four countries

Authors: R. Westerling, A. Daryani, O. Gershuni, K. Czabanowska, H. Brand, F. Erdsiek, T. Aksakal, S. Uner, O. Karadag Caman, H. Ozcebe, P. Brzoska

Published in: Globalization and Health | Issue 1/2020

Login to get access

Abstract

Background

Antimicrobial resistance is considered one of the major threats to global health. The emergence of resistant microorganisms is a consequence of irrational use of antibiotics. In Turkey, the consumption of antibiotics is relatively high and antibiotics are among the most commonly used drugs. However, Turkey has adopted new, more restrictive policies and regulations on antibiotics. In addition, Turkish migrants to EU countries, such as Germany, the Netherlands and Sweden, may encounter health systems that promote a more restrictive and rational antibiotic use.
The objective of this paper was to explore the variation in implemented policies related to rational antibiotic use that citizens in Turkey and Turkish migrants in Germany, the Netherlands and Sweden are subjected to and to discuss the implications for the promotion of rational antibiotic use.
Data were collected through focus groups and individual interviews with citizens, physicians and pharmacists in the four countries. In total, 130 respondents were interviewed. Content analysis was used.

Results

Three relevant themes were identified: Implementation of regulations and recommendations, Access to antibiotics and Need for health communication. Irrational use of antibiotics was reported mainly in Turkey. While it had become less likely to get antibiotics without a prescription, non-prescribed antibiotics remained a problem in Turkey. In the three EU countries, there were also alternative ways of getting antibiotics. Low levels of knowledge about the rational antibiotic use were reported in Turkey, while there were several sources of information on this in the EU countries. Communication with and trust in physicians were considered to be important. There were also system barriers, such as lacking opportunities for physicians to manage care in accordance with current evidence in Turkey and factors limiting access to care in EU countries.

Conclusions

Several fields of importance for promoting rational antibiotic use were identified. There is a need for harmonisation of health-related regulations and policy programmes. Antibiotics should only be available with a prescription. Programmes for rational antibiotic use should be implemented on a broad scale, in medical care, at pharmacies and in the population. Methods for health communication and patient-centred care should be further developed and implemented in this field.
Literature
1.
go back to reference Laxminarayan R, Matsoso P, Pant S, Brower C, Røttingen JA, Klugman K, Davies S. Access to effective antimicrobials: a worldwide challenge. Lancet. 2016;387(Jan 9):168–75.CrossRef Laxminarayan R, Matsoso P, Pant S, Brower C, Røttingen JA, Klugman K, Davies S. Access to effective antimicrobials: a worldwide challenge. Lancet. 2016;387(Jan 9):168–75.CrossRef
2.
go back to reference Davies J, Davies D. Origins and evolution of antibiotic resistance. Microbiol Mol Biol Rev. 2010;74(3):417–33.CrossRef Davies J, Davies D. Origins and evolution of antibiotic resistance. Microbiol Mol Biol Rev. 2010;74(3):417–33.CrossRef
4.
go back to reference World Health Organization. Worldwide Country Situation Analysis: Response to Antimicrobial Resistance. Geneva: WHO Press; 2015. World Health Organization. Worldwide Country Situation Analysis: Response to Antimicrobial Resistance. Geneva: WHO Press; 2015.
10.
go back to reference Surveillance of antimicrobial resistance in Europe Annual report of the European Antimicrobial Resistance Surveillance Network (EARS-Net) 201. 2017. Surveillance of antimicrobial resistance in Europe Annual report of the European Antimicrobial Resistance Surveillance Network (EARS-Net) 201. 2017.
11.
go back to reference Antimicrobial consumption Annual Epidemiological Report European Centre for Disease Prevention and Control. 2017. Antimicrobial consumption Annual Epidemiological Report European Centre for Disease Prevention and Control. 2017.
12.
go back to reference Versporten A, Bolokhovets G, Ghazaryan L, Abilova V, Pyshnik G, Spasojevic T, Korinteli I, Raka L, Kambaralieva B, Cizmovic L, Carp A, Radonjic V, Maqsudova N, Celik HD, Payerl-Pal M, Pedersen HB, Sautenkova N. Goossens H; WHO/Europe-ESAC project group. Antibiotic use in eastern Europe: a cross-national database study in coordination with the WHO regional office for Europe. Lancet Infect Dis. 2014;14(5):381–7.CrossRef Versporten A, Bolokhovets G, Ghazaryan L, Abilova V, Pyshnik G, Spasojevic T, Korinteli I, Raka L, Kambaralieva B, Cizmovic L, Carp A, Radonjic V, Maqsudova N, Celik HD, Payerl-Pal M, Pedersen HB, Sautenkova N. Goossens H; WHO/Europe-ESAC project group. Antibiotic use in eastern Europe: a cross-national database study in coordination with the WHO regional office for Europe. Lancet Infect Dis. 2014;14(5):381–7.CrossRef
13.
go back to reference Paget JLD, Versporten A, Goossens H, van Dijk L. Antimicrobial resistance and causes of non-prudent ude of antibiotics in human medicine in the EU: European Commission. Directorate Gen Health Food Saf. 2017.. Paget JLD, Versporten A, Goossens H, van Dijk L. Antimicrobial resistance and causes of non-prudent ude of antibiotics in human medicine in the EU: European Commission. Directorate Gen Health Food Saf. 2017..
14.
go back to reference Grigoryan L, Haaijer-Ruskamp FM, Burgerhof JG, Mechtler R, Deschepper R, Tambic-Andrasevic A, Andrajati R, Monnet DL, Cunney R, Di Matteo A, Edelsein H, Valinteliene R, Alkerwi A, Scicluna E, Grzesiowski P, Bara AC, Tesar T, Cizman M, Campos J, Lundborg CS, Birkin J. Self-medication with antimicrobial drugs in Europe. Emerg Infect Dis. 2006;12(3):452–9.CrossRef Grigoryan L, Haaijer-Ruskamp FM, Burgerhof JG, Mechtler R, Deschepper R, Tambic-Andrasevic A, Andrajati R, Monnet DL, Cunney R, Di Matteo A, Edelsein H, Valinteliene R, Alkerwi A, Scicluna E, Grzesiowski P, Bara AC, Tesar T, Cizman M, Campos J, Lundborg CS, Birkin J. Self-medication with antimicrobial drugs in Europe. Emerg Infect Dis. 2006;12(3):452–9.CrossRef
15.
go back to reference Karabay O, Hoşoğlu S, Güçlü E, Akalin Ş, Altay FA, Aydin E, Ceylan B, Çelik A, Çelik İ, Demirdal T, Demirli K, Erben N, Erkorkmaz Ü, Erol S, Evirgen Ö, Gönen İ, Güner AE, Güven T, Kadanali A, Koçoğlu ME, Kökoğlu ÖF, Küçükbayrak A, Sargin F, Sünnetçioğlu M, Şenol Ş, İşikgöz Taşbakan M, Tekin R, Turhan V, Yilmaz G, Dede B. Impact of antimicrobial drug restrictions on doctors' behaviors. Turk J Med Sci. 2016;46(1):133–8.CrossRef Karabay O, Hoşoğlu S, Güçlü E, Akalin Ş, Altay FA, Aydin E, Ceylan B, Çelik A, Çelik İ, Demirdal T, Demirli K, Erben N, Erkorkmaz Ü, Erol S, Evirgen Ö, Gönen İ, Güner AE, Güven T, Kadanali A, Koçoğlu ME, Kökoğlu ÖF, Küçükbayrak A, Sargin F, Sünnetçioğlu M, Şenol Ş, İşikgöz Taşbakan M, Tekin R, Turhan V, Yilmaz G, Dede B. Impact of antimicrobial drug restrictions on doctors' behaviors. Turk J Med Sci. 2016;46(1):133–8.CrossRef
17.
go back to reference Rechel B, Maresso A, Sagan A, Hernández-Quevedo C, Richardson E, Jakubowski E, McKee M, Nolte E, editors. The role of public health organizations in addressing public health problems in Europe: The case of obesity, alcohol and antimicrobial resistance [Internet]. European Observatory Health Policy Series European Observatory on Health Systems and Policies. 2018. Rechel B, Maresso A, Sagan A, Hernández-Quevedo C, Richardson E, Jakubowski E, McKee M, Nolte E, editors. The role of public health organizations in addressing public health problems in Europe: The case of obesity, alcohol and antimicrobial resistance [Internet]. European Observatory Health Policy Series European Observatory on Health Systems and Policies. 2018.
18.
go back to reference Machowska A, Stålsby LC. Drivers of irrational use of antibiotics in Europe. Int J Environ Res Public Health. 2018;16(1):27.CrossRef Machowska A, Stålsby LC. Drivers of irrational use of antibiotics in Europe. Int J Environ Res Public Health. 2018;16(1):27.CrossRef
19.
go back to reference Wångdahl J, Lytsy P, Mårtensson L, Westerling R. Poor health and refraining from seeking healthcare are associated with comprehensive health literacy among refugees: a Swedish cross-sectional study. Int J Public Health. 2018;63(3):409–19.CrossRef Wångdahl J, Lytsy P, Mårtensson L, Westerling R. Poor health and refraining from seeking healthcare are associated with comprehensive health literacy among refugees: a Swedish cross-sectional study. Int J Public Health. 2018;63(3):409–19.CrossRef
Metadata
Title
Promoting rational antibiotic use in Turkey and among Turkish migrants in Europe – implications of a qualitative study in four countries
Authors
R. Westerling
A. Daryani
O. Gershuni
K. Czabanowska
H. Brand
F. Erdsiek
T. Aksakal
S. Uner
O. Karadag Caman
H. Ozcebe
P. Brzoska
Publication date
01-12-2020
Publisher
BioMed Central
Keywords
Antibiotic
Care
Published in
Globalization and Health / Issue 1/2020
Electronic ISSN: 1744-8603
DOI
https://doi.org/10.1186/s12992-020-00637-5

Other articles of this Issue 1/2020

Globalization and Health 1/2020 Go to the issue